Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients
- 21 February 2018
- journal article
- review article
- Published by Springer Nature in World Journal of Urology
- Vol. 36 (7) , 1019-1029
Abstract
Preoperative blood-based inflammatory biomarkers have been suggested to improve staging and prognostication in patients with upper-tract urothelial carcinoma (UTUC). Neutrophil-to-lymphocyte ratio (NLR) is the most studied blood-based biomarker. NLR is an indicator of systemic inflammation and has been shown to be associated with a poor prognosis in various malignancies. The aim of this study was to analyze the current evidence regarding the prognostic significance of preoperative NLR in patients undergoing radical nephroureterectomy (RNU) for UTUC to assess its prognostic potential.Keywords
This publication has 50 references indexed in Scilit:
- Preoperative Neutrophil-Lymphocyte Ratio as an Independent Prognostic Marker for Patients With Upper Urinary Tract Urothelial CarcinomaClinical Genitourinary Cancer, 2013
- Gender‐specific effect of smoking on upper tract urothelial carcinoma outcomesBJU International, 2013
- Risk of Cancer-specific Mortality following Recurrence After Radical NephroureterectomyAnnals of Surgical Oncology, 2012
- The Impact of Tumor Multifocality on Outcomes in Patients Treated With Radical NephroureterectomyEuropean Urology, 2012
- Neutrophils in the activation and regulation of innate and adaptive immunityNature Reviews Immunology, 2011
- Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle‐invasive and non‐organ confined disease in patients with upper tract urothelial carcinomaBJU International, 2011
- Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005BJU International, 2010
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TANCancer Cell, 2009
- Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi‐institutional analysis of 1363 patientsBJU International, 2009
- NOMOGRAMS INCLUDING NUCLEAR MATRIX PROTEIN 22 FOR PREDICTION OF DISEASE RECURRENCE AND PROGRESSION IN PATIENTS WITH Ta, T1 OR CIS TRANSITIONAL CELL CARCINOMA OF THE BLADDERJournal of Urology, 2005